Americas

The Spring Clinical Meetings (SCM) is NKF’s premiere educational event designed for the interprofessional kidney health team. SCM presents a unique opportunity for busy renal health care professionals to explore innovation, research, and best clinical practice within nephrology.

Whether you are a clinical research novice or veteran, work with a study sponsor, research site or CRO, MAGI will offer best-in-class educational opportunities for all career levels in support of your continuing education and your professional growth and success.

Bloom Burton is hosting its annual Healthcare Investor Conference in Toronto, Canada. We’ve invited 66 of Canada’s premier publicly-traded and venture-backed private companies together with the most promising pre-venture companies in the healthcare industry.

Biotechgate Digital Partnering is a virtual conference designed to support the business development of Biotech, Medtech and Pharma companies. Join five days of digital partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings, along with informal networking events and workshops.

Empowering innovation, accelerating investment and facilitating knowledge and networking to shape the future of healthcare Where innovators, investors and senior life science dealmakers in the LSX community connect, learn and partner

This prestigious conference is an exclusive global partnering forum that brings together nearly 600 senior executives and CEOs, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies from over 20 countries. This conference features panel discussions and keynote presentations, one-on-one partnering meetings, small company presentations, presentations from leading research institutions, and endless networking opportunities

[From 2021] The BIO Investor Forum Digital is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and BIO One-on-One Partnering™ meetings.

For more than 20 years, the BIO CEO & Investor Conference has fueled the biotech industry networking with premier investor and banking communities, focused on established and emerging publicly traded and select private biotech companies. 

The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies, where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.

Join thousands of international thought leaders to discuss the latest research, technologies, innovation and business models in implementing precision medicine, biomarkers and companion diagnostics, genomic medicine, and precision health; innovation and market access strategies for at-home diagnostics, point-of-care testing and molecular diagnostics for infectious diseases; liquid biopsy and advanced diagnostics for precision oncology, including Multi-Cancer Early Detection and Minimal Residual Disease testing; and emerging technologies for spatial biology and single-cell multiomics.

The Association of American Cancer Institutes (AACI) Clinical Research Innovation (CRI) program serves as a network for research leaders to develop and share best practices for the efficient operation of clinical trials offices (CTO) at AACI cancer centers. The programming of the 14th Annual AACI CRI Meeting, “Partnering in Progress,” aligns with CRI’s strategic goal of stimulating cancer center interactions to maximize resources by creating opportunities for peer-to-peer networking and collaboration.